Dyadic International Inc DYAI

Healthcare Biotechnology

Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Its lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

NDAQ:DYAI - Post by User

Dyadic International Inc

<< Previous

Bullboard Posts

Next >>

Post by schoolofrockon Oct 14, 2020 6:56am

112 Views

Post# 31712620

TODAY - Virtual Roadshow with Dyadic CEO Mark Emalfarb

TODAY - meet with Dyadic President & CEO Mark Emalfarb. Tune in, ask questions, no charge

https://attendee.gotowebinar.com/register/3580219176031606541

User image